Human Immunodeficiency Virus Treatment and Prevention for Pregnant and Postpartum Women in Global Settings
Review and description of current HIV prevention, specifically PMTCT, strategies in pregnant and breastfeeding women, including ART during pregnancy/breastfeeding and lifelong ART for women living with HIV, PrEP use during pregnancy/breastfeeding for women not living with HIV, and integrating other HIV prevention services with PrEP. However, more work needs to be done in implementing evidence-based practices (as listed above) in high-burden, low-resource settings. Possible strategies include integration of HIV testing with routine antenatal care, differentiated care models, and postnatal adherence clubs.
Resource Details
- Study Type
- Review
- Year
- 2022
- Population
- Pregnant & Postpartum Women
- Author
- Saidi F, Chi BH
- Source
- Obstet Gynecol Clin N Am
More Publications & Resources
Providing PrEP to Pregnant and Breastfeeding Women
Clinical Practice Guidelines for Providing PrEP for Pregnant and Breastfeeding Populations
Guidelines on Lenacapavir for HIV Prevention and Testing Strategies for Long-Acting Injectable Pre-Exposure Prophylaxis
PrEP and PEP Guidelines-Zambia
PrEP Lenacapavir Implementation Guidelines
Provider Training Toolkit on Use of Oral and Long-acting HIV PrEP: Lenacapavir-Focused Learning Pathway (Lessons 1-4)
Provider Training Toolkit on Use of Oral and Long Acting HIV PrEP
Inclusion of Pregnant and Lactating People in the PURPOSE 1 Study: Efficacy, Safety, and Pharmacokinetics
Lenacapavir Provider Tools and Job Aids
PrEP Drug Interactions
Zambia PrEP Training Materials for Clinicians and Community Mobilisers
No results found.